Howard W Robin

President & CEO, Director, Nektar Therapeutics

Bought, 12 months

$0.0M

Sold, 12 months

$1.4M

Companies

Latest trade

Aug 18, 2026

Companies

Nektar TherapeuticsPresident & CEO, Director −$1.4M

Trades

NKTR Sold 418 shares at $71.98 $0.0M Aug 18

NKTR Sold 10,000 shares at $61.19 · planned $0.6M Jun 17

NKTR Sold 10,000 shares at $60.32 · planned $0.6M Jun 16

NKTR Sold 444 shares at $65.51 $0.0M May 19

NKTR Sold 423 shares at $73.00 $0.0M Feb 18

NKTR Sold 2,207 shares at $54.28 $0.1M Nov 25

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.